<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mass spectrometry (MS)-based quantitative proteomics plays important roles in drug discovery </plain></SENT>
<SENT sid="1" pm="."><plain>In this chapter, we describe a stable isotope labeling technique which employs 4-plex iTRAQ(â„¢) isobaric reagents coupled with two-dimensional (2-D) liquid chromatography (LC) and MALDI-TOF/TOF MS, for a temporal study of HCT-116 colon <z:mp ids='MP_0002038'>carcinoma</z:mp> cells treated with <z:chebi fb="0" ids="17968">butyrate</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="17968">Butyrate</z:chebi> is a <z:chebi fb="0" ids="26666">short-chain fatty acid</z:chebi> fermentation by-product of fiber that can induce temporal cell maturation, from the early phase of <z:mpath ids='MPATH_73'>growth arrest</z:mpath>, to differentiation, and to the activation of apoptotic cascades </plain></SENT>
<SENT sid="3" pm="."><plain>Our quantitative proteomics study uncovered several integrated cellular processes and pathways involved in <z:mpath ids='MPATH_73'>growth arrest</z:mpath>, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Selected protein targets are validated by real-time PCR and western blotting </plain></SENT>
</text></document>